Cargando…
Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after (125)I Particle Therapy for Differentiated Thyroid Cancer
OBJECTIVE: To analyze the influencing factors of tumor volume, body immunity, and poor prognosis after (125)I particle therapy for differentiated thyroid cancer. METHODS: A total of 104 patients with differentiated TC who were treated with (125)I particles during January 2020 to January 2021 was pic...
Autores principales: | Tan, Liling, Chen, Zhijun, Wang, Wenjun, Su, Yu, Wu, Zhen, Yi, Ling, Zheng, Zhipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171980/ https://www.ncbi.nlm.nih.gov/pubmed/37181804 http://dx.doi.org/10.1155/2023/8130422 |
Ejemplares similares
-
Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma
por: Chen, Wei, et al.
Publicado: (2021) -
Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014) -
SUN-474 An Unusual Case of Poorly Differentiated Thyroid Carcinoma with an Excellent Prognosis
por: Pulipati, Vishnu Priya, et al.
Publicado: (2020) -
(125)I Seed Brachytherapy for Refractory Loco-Regional Recurrence of Non-Anaplastic Thyroid Cancer
por: Yu, Huimin, et al.
Publicado: (2022) -
Prognosis. Volume I. 1935
Publicado: (1936)